ArticleNature communications2025
Biomimetic transmembrane transport of multi-enzymes to fabricate heterogeneous bioreactors with photoenzymatic reduction of CO
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The cascade of bio-/chemo-catalysis with quantitative integration and optimal activity is vital for catalytic conversion, but highly challenging. Here, we innovate a co-immobilization strategy by mimicking cellular transmembrane transport using ionic covalent organic framework capsules (iCOFcap) to co-encapsulate multi-enzymes and chemocatalysts. Thanks to the swellable polyethylene glycol and the adjustable charge of iCOFcap shells, multi-enzymes can be adsorbed onto the iCOFcap shells and then transported stepwise into the inner cavity of iCOFcap by adjusting electrostatic interaction between the enzymes and iCOFcap. Thus, the iCOFcap enables both transmembrane transport multi-enzymes and one-pot pre-encapsulation of chemocatalysts to construct various cascade catalysts, enabling quantitative integration and nearly complete retention of enzyme activity. The formed heterogeneous cascade catalysts show excellent comprehensive performance for CO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.